SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 201,960 shares at $25.81 ($5.3M) on 2023-01-09, disclosed to the SEC on 2023-01-10.
Open-market sale of $5.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.76 | 9,398 | $242K | 4.6% |
| 2 | $25.76 | 9,398 | $242K | 4.6% |
| 3 | $26.19 | 56,781 | $1.5M | 28.3% |
| 4 | $26.19 | 56,781 | $1.5M | 28.3% |
| 5 | $25.81 | 29,827 | $770K | 14.6% |
| 6 | $25.81 | 29,827 |
| $770K |
| 14.6% |
| 7 | $26.11 | 4,974 | $130K | 2.5% |
| 8 | $26.11 | 4,974 | $130K | 2.5% |
| Total | $26.03 avg | 201,960 | $5.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |